LIQUENT InSight® for Registration XPress Edition is the latest release of LIQUENT's regulatory information management platform. LIQUENT InSight® provides clients with global registration management ...
New Solution in Line with Independent Market Research That Forecasts Increased Uptake in Electronic Regulatory Document Management Technologies DRUG INFORMATION ASSOCIATION ANNUAL MEETING--Liquent, ...
London, 31 March, 2015 - PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today introduced the latest version of its Regulatory Information ...
BRUNNTHAL, Germany--(BUSINESS WIRE)--Oct. 18, 2004--12:00:00 AM - Liquent, Inc. today announced that Bayer Healthcare (BHC), an independent subgroup of Bayer AG, Leverkusen, has selected Liquent ...
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today introduced the latest version of its Regulatory Information Management (RIM) platform: ...
Liquent, Inc. (“Liquent”), a leading provider of software and service solutions designed to support the regulatory business processes of life sciences companies, is pleased to announce that it has ...
PHILADELPHIA and LONDON, June 27 /PRNewswire/ -- Thomson Scientific today announced that Liquent is poised to release its next-generation electronic publishing solution, Liquent InSight(R) Publisher.
HORSHAM, Pa., Sept. 8 /PRNewswire/ -- Liquent Inc., the global leader in regulatory information management solutions and services, revealed today its new solution branding positioning. The ...
BOSTON, Dec. 27, 2012 -- PAREXEL International Corporation announced today that on December 21, 2012, the Company acquired all of the outstanding equity securities of Liquent, Inc., a leading global ...
HORSHAM, Pennsylvania, January 6 /PRNewswire/ — Liquent, Inc. (“Liquent”), a leading provider of software and servicesolutions designed to support the regulatory business processes of lifesciences ...
US-based bio/pharmaceutical services organisation Parexel International has beefed up its regulatory support capabilities by acquiring Liquent Inc for around US$72 million. US-based bio/pharmaceutical ...
Harris Williams & Co., a preeminent middle market investment bank focused on the advisory needs of clients worldwide, announces the sale of Liquent, Inc. to PAREXEL International Corporation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results